ArticlePharmacoEconomics2015
Healthy decisions: towards uncertainty tolerance in healthcare policy.
Article in PharmacoEconomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Moderators uncertainty tolerance (UT) in healthcare: a systematic review.Advances in health sciences education : theory and practice · 2023Pooled it
- Article
- A case study integrating scenario thinking with dialysis policymaking in Thailand.Communications medicine · 2025Article
- Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia.PharmacoEconomics · 2025Article
- Views and opinions of the general public about the reimbursement of expensive medicines in the Netherlands.PloS one · 2025Article
- Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.International journal of technology assessment in health care · 2023Article
- Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP".International journal of technology assessment in health care · 2023Article
- Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.PharmacoEconomics · 2020Article
- Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling.International journal of health policy and management · 2019Article
- The Australian Managed Entry Scheme: Are We Getting it Right?PharmacoEconomics · 2018Review
- The development of scientific evidence for health policies for obesity: why and how?International journal of obesity (2005) · 2017Review
- Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.PharmacoEconomics · 2016Article
- Preferences for engagement in health technology assessment decision-making: a nominal group technique with members of the public.BMJ open · 2016Article
- Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".PharmacoEconomics · 2015Article
- The Authors' Reply: Comment on "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".PharmacoEconomics · 2015Article
- Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions.MDM policy & practiceArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25145801What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.